How do healthcare policies and systems prioritize genetic testing and genomics in personalized medicine?
Abstract
Genomics and genetic testing are prioritized in personalized medicine through evidence of clinical benefit and public interest, yet face challenges such as cost, ethics, and system capability constraints.
Fields of Study & Subjects
Genomics and Rare Diseases
Biomedical Ethics and Regulation
Health Systems
Economic Evaluations
Quality of Life
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 26 February 2026
- Language
- EN